Finance

Beta
Lists
ARTV:NASDAQ
Artiva Biotherapeutics Inc
$7.34
+5.31%
(+0.37) 1D
Jun 4, 2:13:42 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARTV...
Open
$6.84
High
$7.38
Low
$6.84
Mkt. cap
356.64M
Avg. vol.
556.99K
Volume
187.84K
52-wk high
$14.53
52-wk low
$1.47
EPS
-$3.55
Shares outstanding
24.72M
No. of employees
106
Open
$6.84
High
$7.38
Low
$6.84
Mkt. cap
356.64M
Avg. vol.
556.99K
Volume
187.84K
52-wk high
$14.53
52-wk low
$1.47
EPS
-$3.55
Shares outstanding
24.72M
No. of employees
106
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to ARTV in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ARTV in the last 3 months.
Highest
Current $7.34
$41.00 (+458.58%)
Average
$35.80 (+387.74%)
Lowest
$23.00 (+213.35%)
News stories
From sources across the web
About Artiva Biotherapeutics Inc
CEO-
Employees106
Founded2019
Headquarters-
SectorBiotechnology
Websiteartivabio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.86M
17.63M
16.99M
19.31M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.95M
5.26M
4.94M
5.12M
Operating expense
22.81M
22.90M
21.93M
24.43M
Total operating expenses
22.81M
22.90M
21.93M
24.43M
Operating income
-22.81M
-22.90M
-21.93M
-24.43M
Other non operating income
-5.00K
-3.00K
-1.88M
2.00K
EBT including unusual items
-21.25M
-21.53M
-20.77M
-23.52M
EBT excluding unusual items
-21.25M
-21.53M
-22.65M
-23.52M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21.25M
-21.53M
-20.77M
-23.52M
Net profit margin
-
-
-
-
Earnings per share
-0.87
-0.88
-0.84
-0.95
Interest and investment income
1.56M
1.37M
1.16M
912.00K
Interest expense
-
-
-
-
Net interest expenses
1.56M
1.37M
1.16M
912.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.17M
-22.24M
-21.27M
-23.76M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer